Asset Details
Do you wish to reserve the book?
Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
Do you wish to request the book?
Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
2013
Overview
21-Hydroxylase deficiency (21-OHD) is the most common cause of congenital adrenal hyperplasia (CAH), resulting from deletions or mutations of the P450 21-hydroxylase gene (CYP21A2). Children with 21-OHD need chronic glucocorticoid (cGC) therapy, both to replace congenital deficit in cortisol synthesis and to reduce androgen secretion by adrenal cortex. GC-induced osteoporosis (GIO) is the most common form of secondary osteoporosis that results in an early, transient increase in bone resorption accompanied by a decrease in bone formation, maintained for the duration of GC therapy. Despite the conflicting results in the literature about the bone status on GC-treated patients with 21-OHD, many reports consider these subjects to be at risk for osteoporosis and fractures. In bone cells, at the molecular level, GCs regulate various functions including osteoblastogenesis, osteoclastogenesis, and the apoptosis of osteoblasts and osteocytes. In this paper, we focus on the physiology and biosynthesis of endogenous steroid hormones as well as on the effects of GCs on bone cells, highlighting the pathogenetic mechanism of GIO in children with 21-OHD.
Publisher
Hindawi Publishing Corporation,John Wiley & Sons, Inc
Subject
/ Adrenal Hyperplasia, Congenital - drug therapy
/ Adrenal Hyperplasia, Congenital - metabolism
/ Adrenal Hyperplasia, Congenital - pathology
/ Child
/ Children
/ Complications and side effects
/ Female
/ Glucocorticoids - adverse effects
/ Glucocorticoids - therapeutic use
/ Humans
/ Infant
/ Male
/ Mutation
/ Osteoporosis - chemically induced
/ Review
